This spring, Dr. George Lewis, founder and CEO of ZetrOZ Systems, will present new research on the effectiveness of the Sustained Acoustic Medicine (sam) wearable ultrasound device on soft-tissue injuries at a series of sports medicine symposiums with physicians, physical therapists, and athletic trainers.

Lewis and the ZetrOZ team will be attending conferences in Birmingham, Ala; Charlotte, NC; Chicago, Dallas, Indianapolis; Jacksonville, Fla; Las Vegas, Philadelphia, and Tampa, Fla.

The ZetrOZ team will present new clinical data from 2021 on sam and soft tissue injury healing, including sports-related muscle and tendon injuries, using sam to stimulate tissue remodeling and return athletes to competition, and using sam to prevent injury for the treatment of chronic or past-injury sites.

“When you’re participating in physical activity, the risk of injury is always possible,” Lewis says. “Independent research conclusively shows that sam speeds the rate of healing from those injuries and gets them back to practice and competition. Getting our word out to the health care providers who work in sports medicine can elevate the standard of care for athletes at all levels.”

FDA-Cleared Wearable Ultrasound

ZetrOZ’s sam is an FDA-cleared, long-duration, home use, pain relief ultrasound device designed for easy daily use as necessary. More than 30 peer-reviewed studies have found it to be an innovative and effective treatment to relieve pain, restore function, and return patients back to sports and other daily activities. Its low-intensity continuous ultrasound therapy treats deep tissue injuries by inhibiting inflammation and increasing the rate of tissue regeneration, angiogenesis, and nutrient exchange. 

A recent critical review of over 100 elite sports medicine health care providers in Atlanta found:

  • 93% of athletes responded to sam in less than 2 weeks.
  • 85% use sam for two to eight hours per day
  • 82% of health care providers were able to reduce patients’ need for oral pain medication
  • 87% of athletes who had shown no improvement after conservative physical therapy made notable improvements with sam therapy.
  • 50% of those athletes returned to sport after 2 weeks of sam treatment

Patients typically undergo treatment for 4 to 8 weeks, and each treatment includes the sam wearable ultrasound device and five to eight packs of ultrasound coupling patches.

Source(s): ZetrOZ Systems, GlobeNewswire]

Related Content:
ZetrOZ Signs 5-Year Agreement With US Government to Supply Employees and Military With SAM Technology
Study Affirms SAM as Adjunct or Standalone Therapy to Help Reduce Pain from Sports Injuries